Newsletter | May 27, 2025

05.27.25 -- Good Distribution Practice Is Evolving — Here's How

SPONSOR

Did you know Catalent offers contracted analytical services?

With over 30+ years of experience, Catalent offers a comprehensive suite of orthogonal GMP analytical services for all biological modalities, from discovery to commercial phases. Our seasoned experts ensure exceptional on-time delivery and client satisfaction by providing tailored solutions to meet your unique needs—no matter the complexity, scale, or timeline. Watch our intro video to learn more about our capabilities!

FOCUS ON OUTSOURCING

Good Distribution Practice Is Evolving — Here's How

Managing a global supply chain for increasingly complex biologic drugs takes special attention and expertise. Explore the key drivers of a modern logistics management plan.

Overcoming Challenges In Combination Product Manufacturing

Blending pharmaceuticals and medical devices into a single product offers immense potential for patient care, but manufacturing these combination products presents unique hurdles.

Accelerate Your Pipeline With CDMO Collaboration

A CDMO can augment your capacity and expertise, refine your processes, and ultimately shorten your time to market. Explore best practices that make working with a CDMO as efficient as possible.

How Platform Technologies Power Up Processes From Lab To cGMP

This expert Q&A examines ways to push the envelope of expression system technology and process characterization while maximizing user transparency.

Nanoparticle Enabled Formulation And Drug Delivery Solutions

Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.

Partners For The Planet: Sustainability Review

In this report, explore concrete examples of projects across a global network that are contributing to the successful achievement of sustainability goals and aspirations.

Expanding The Boundaries Of Sub-Cutaneous Injections

As the field of biologics increases its focus on identifying new diseases to target and novel constructs to treat them, innovative administration devices are once again in the spotlight.

OUTSOURCING SOLUTIONS

Unraveling ADC Complexities With Bio-Logic Brilliance - Pfizer CentreOne

Navigating The Future: For Each And Every Patient - GC Cell

Codex HiCap RNA Polymerase - Aldevron

Capacity Update July 2024: Large Molecule Development - Aton Biotech

Connect With Bioprocess Online: